Experienced researchers are less likely to produce ‘disruptive’ science than are those just starting their careers, finds an analysis of the scientific papers published by 12.5 million researchers over 60 years.
https://t.co/b3L5aP3AWw
🧬 New paper out in @Nature! We used CRISPR to selectively kill cancer cells based on a single-letter mutation in their RNA. The story I want to highlight: KRAS — one of the most notorious drivers of human cancer. A short thread on what we found 🧵
We've known how important the tumor microenvironment is for cancer progression and treatment, but we never had a non-invasive blood test to assess it. Today, as reported @nature, one has been discovered https://t.co/rDaF5YUwTq
1/ Thrilled to share our new paper, out today in @Nature: "Non-invasive profiling of the tumour microenvironment with spatial ecotypes".
Paper (open access): https://t.co/EujZFqU7wi
In case you missed it: @opendesciorg is now officially partnering with @BytenovaAI
We’re bringing AI to the edge of science — combining ByteNova’s containerized GPU infrastructure with our decentralized research stack 🧠⚡
This means:
-Real-time AI processing for research
-Decentralized IP ownership
-Scalable deployments for labs & institutions
Together, we’re making science faster, fairer, and closer to the people.
🧪 Now we want to hear from you:
What case study should we tackle next?
→ Climate?
→ Genomics?
→ Open drug discovery?
Drop your ideas 👇
Therapeutic #ExtracellularVesicles were a huge theme at the recent #ISEV2025. Learn more at the next #EVClub! Gi-Hoon Nam, MD, PhD presents "Dual-mode action of scalable, high-quality engineered stem cell-derived SIRPα-EVs for treating acute liver failure" https://t.co/fA49vHhZXQ
Please note the different time:
Asia-Pacific: Wednesday, May 7, 7 AM China/8 AM Korea, Japan/9AM AEST
Americas: Tuesday, May 6, 7 PM EDT
Need the login? https://t.co/rlKrHdZU3I
@IsevOrg@LabWitwer
A great talk by @OlesiaPhd at #ISEV2025, highlighting why we shouldn't assume that all EVs are non immunogenic, and why we must test EVs in diverse model systems to ensure safety and efficacy. @IsevOrg@LabWitwer
Engineered microparticles loaded with succinate can convert tumor-associated macrophages back into a tumor-suppressing form, suggesting similar approaches could be valuable tools in immunotherapy.
Learn more in @ScienceTM: https://t.co/HCwVuj6o4y
Multitasking is a lie.
In reality, you’re rapidly switching back & forth between tasks.
Each switch costs you cognitive resources & depletes them more quickly than when you focus on a single task.
Focused work will get you the results you want.
Microbubble array-based acoustofluidic chips enable label-free isolation of exosome subpopulations from whole blood within three minutes—a critical advancement for exosome-based diagnostics, therapeutics, and biomedical research.
Learn more: https://t.co/M92d1ky1DT
Hi Friends,
I wanted to share a crowdfunder for this amazing Pakistani iGEM team looking to raise for their entrance fee expenses. Please share, and if you have the means to even a little donation would help. Let's get these biologists to the jamboree!
https://t.co/lEpkG2d6cF